QRG Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

QRG Capital Management’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,306	Closed	-$47K	–	1239
2026 Q1	$47K	Buy	+15,306	New	+$59.1K	﹤0.01%	1133
2025 Q3	–	Sell	-19,366	Closed	-$98K	–	1151
2025 Q2	$98K	Sell	19,366 -9,149	-32%	-$44.9K	﹤0.01%	1104
2025 Q1	$151K	Buy	28,515 +2,244	+9%	+$16.4K	﹤0.01%	1051
2024 Q4	$178K	Buy	26,271 +8,008	+44%	+$53.8K	﹤0.01%	1048
2024 Q3	$120K	Buy	+18,263	New	+$131K	﹤0.01%	1068
2023 Q4	–	Sell	-11,295	Closed	-$86.4K	–	1063
2023 Q3	$86.4K	Buy	+11,295	New	+$113K	﹤0.01%	967

Other funds holding RXRX

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

Accel Wealth Management Waverly, Iowa $444M AUM 31.14% 1-Year Est. Return

National Wealth Management Group Cincinnati, Ohio $323M AUM 39.23% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

Integral Investment Advisors Turlock, California $454M AUM 21.42% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return